ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.48%
US Tech 100
17,833.60
0.62%
다우존스 지수
39,558.11
0.32%
Bitcoin
61,605.22
-2.06%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Orchard Therapeutics PLC (ORTX)

  7. Orchard Therapeutics PLC (ORTX) 뉴스

ORTX Orchard Therapeutics PLC

16.70
0.00 (0.00%)
시간외 거래
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Orchard Therapeutics PLC ORTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 16.70 09:00:00
개장가 저가 고가 종가 전일 종가
16.70 16.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202420:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
03/05/202420:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
20/03/202420:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
19/03/202404:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
15/02/202411:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202404:39EDGAR2Form 15-12G - Securities registration termination [Section..
05/02/202421:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
02/02/202421:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
31/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
25/01/202421:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
25/01/202407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
25/01/202406:28EDGAR2Form POS AM - Post-Effective amendments for registration..
25/01/202406:17EDGAR2Form 8-K - Current report
24/01/202419:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
23/01/202406:10EDGAR2Form 8-K - Current report
20/12/202306:49EDGAR2Form 8-K - Current report
11/12/202321:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
09/12/202306:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/12/202306:37EDGAR2Form 8-K - Current report
01/12/202306:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202306:06EDGAR2Form 8-K - Current report
30/11/202321:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
21/11/202321:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/11/202321:51EDGAR2Form 8-K - Current report
17/11/202306:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
13/11/202321:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202321:05EDGAR2Form 8-K - Current report
13/11/202321:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
04/11/202306:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
27/10/202305:35EDGAR2Form 8-K - Current report
26/10/202320:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
24/10/202320:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
18/10/202305:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202306:26EDGAR2Form DEFA14C - Additional information statement materials,..
06/10/202305:48EDGAR2Form DEFA14C - Additional information statement materials,..
06/10/202305:45EDGAR2Form DEFA14C - Additional information statement materials,..
06/10/202305:43EDGAR2Form DEFA14C - Additional information statement materials,..
06/10/202305:40EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202322:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202322:05EDGAR2Form 8-K - Current report
05/10/202320:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
05/10/202316:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
18/09/202320:07EDGAR2Form 8-K - Current report
18/09/202320:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
31/08/202320:00GLOBEOrchard Therapeutics Announces Presentation of Data..
22/08/202305:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/08/202306:04EDGAR2Form S-8 - Securities to be offered to employees in employee..

최근 히스토리

NASDAQ
ORTX
Orchard Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유